Jim Fong
Corporate Officer/Principal at CTI BIOPHARMA CORP.
Jim Fong active positions
Companies | Position | Start | End |
---|---|---|---|
CTI BIOPHARMA CORP. | Corporate Officer/Principal | 01/01/2008 | - |
Chief Operating Officer | 01/01/2017 | - |
Career history of Jim Fong
Former positions of Jim Fong
Companies | Position | Start | End |
---|---|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Sales & Marketing | - | - |
Training of Jim Fong
University of California, Los Angeles | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Jim Fong
- Experience